Checkpoint protein expression in the tumor microenvironment defines the outcome of classical Hodgkin lymphoma patients

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalBlood advances
Issue number6
Pages (from-to)1919-1931
Number of pages13
Publication statusPublished - 22 Mar 2022
MoE publication typeA1 Journal article-refereed

Fields of Science

  • 3122 Cancers
  • Regulatory t-cells
  • Analysis reveals
  • Brentuximab vedotin
  • Macrophages
  • Blockade
  • Transplantation
  • Pembrolizumab
  • Nivolumab
  • Predicts
  • Survival

Cite this